Raymond James & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-59,600
Closed -$52.4K 3966
2022
Q4
$52.4K Buy
59,600
+11,200
+23% +$1.93M ﹤0.01% 3713
2022
Q3
$43K Sell
48,400
-400
-0.8% -$67.7K ﹤0.01% 3723
2022
Q2
$122K Sell
48,800
-14,300
-23% -$2.55M ﹤0.01% 3641
2022
Q1
$198K Sell
63,100
-2,200
-3% -$374K ﹤0.01% 3672
2021
Q4
$70K Sell
65,300
-20,000
-23% -$3.27M ﹤0.01% 3916
2021
Q3
$51K Buy
85,300
+37,300
+78% +$6.36M ﹤0.01% 3915
2021
Q2
$24K Buy
48,000
+16,200
+51% +$2.68M ﹤0.01% 3973
2021
Q1
$5K Sell
31,800
-4,600
-13% -$744K ﹤0.01% 3967
2020
Q4
$104K Buy
+36,400
New +$5.37M ﹤0.01% 3550
2017
Q2
Sell
-10,800
Closed -$16K 3389
2017
Q1
$16K Buy
+10,800
New +$1.29M ﹤0.01% 3218
2016
Q2
Sell
-13,300
Closed -$4K 3065
2016
Q1
$4K Buy
+13,300
New +$1.38M ﹤0.01% 2910

Other funds holding JNJ

Raymond James & Associates's JNJ Position: Q3 2024 in Review

Raymond James & Associates increased its Johnson & Johnson (JNJ) stake by 9.5% in Q3 2024, buying an estimated $95.1M and bringing the position to 6,864,404 shares worth $1.11B. The position accounts for 0.68% of the portfolio, ranked #22.

Raymond James & Associates first reported a position in JNJ in Q2 2013 and has held it in 46 quarters since. 3,882 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Raymond James & Associates held 6,864,404 shares of Johnson & Johnson worth $1.11B as of Q3 2024.
  • Raymond James & Associates bought 596,984 Johnson & Johnson shares in Q3 2024, an estimated $95.1M.
  • Johnson & Johnson made up 0.68% of Raymond James & Associates's portfolio in Q3 2024, its #22 holding.
  • Raymond James & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 46 quarters since.
  • 3,882 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.